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872Objective: To examine the late outcomes of aortic valve-sparing operations to treat patients with aortic root
aneurysmwith and without aortic insufficiency (AI) in a cohort of patients followed up prospectively since 1988.
Methods: A total of 371 consecutive patients had undergone aortic valve-sparing surgery (mean age, 47  15
years; 78% men) from 1988 through 2010. In addition to the aortic root aneurysm, 47% had moderate or
severe AI, 35.5% had Marfan syndrome, 12.1% had type A aortic dissection, 9.2% had bicuspid aortic valve,
8.4% had mitral insufficiency, 16.1% had aortic arch aneurysm, and 10.2% had coronary artery disease.
Reimplantation of the aortic valve was used in 296 patients and remodeling of the aortic root in 75. Cusp repair
by plication of the free margin along the nodule of Arantius was used in 36.6% of patients, and reinforcement of
the free margin with a double layer of fine Gore-Tex suture in 24.2%. The patients were followed up
prospectively with images of the aortic root for a median follow-up of 8.9  5.2 years.
Results:A total of 4 operative and 39 late deaths occurred. Survival at 18 years was 76.8% 4.31%, lower than
that for the general population matched for age and gender. Age, type A aortic dissection, impaired ventricular
function, and preoperative AI were associated with increased mortality on multivariable analysis. Reoperations
on the aortic valve were performed in 8 patients for recurrent AI and in 2 for infective endocarditis. Freedom
from reoperation on the aortic valve at 18 years was 94.8%  2.0%. No predictors of the need for reoperation
were found on multivariable analysis. Eighteen patients developed AI greater than mild. Freedom from AI
greater than mild at 18 years was 78.0% 4.8%. No predictors of recurrent AI were identified on multivariable
analysis.
Conclusions: Aortic valve-sparing operations continue to provide excellent clinical outcomes, although a
slow but progressive deterioration of aortic valve function seems to occur during the first 2 decades of
follow-up. Preoperative AI and cusp repair had no adverse effect on valve function. (J Thorac Cardiovasc
Surg 2014;148:872-80)A quarter of century has passed since aortic valve-sparing
(AVS) operations were introduced in our cardiac unit.1,2
At first, we were concerned that the aortic cusps would
not function normally for a prolonged period because they
were placed inside a rigid root made of Dacron fabric.
Also, only patients with echocardiographically normal
aortic cusps were offered these operations as an
alternative to aortic root replacement with a valved
conduit.2 As our confidence in AVS operations increased,
we expanded their use to include patients with cuspe Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto
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The Journal of Thoracic and Cardiovascular Surgprolapse due to elongation of the free margin or stress
fenestrations in the commissural areas. We believed these
cusps abnormalities were caused by increased mechanical
stresses resulting from dilatation of the sinotubular junction
and/or aortic annulus. Thus, shortening their free margins
by plication or triangular resection along the nodule of
Arantius and/or reinforcement of the free margin of
the cusp with a double layer of a fine Gore-Tex suture
(W.L. Gore, Inc, Newark, Del), in addition to correction
of the mechanism by which they became abnormal, would
restore aortic valve function and expand the indications
for AVS surgery. These types of cusp repair during AVS
operations have had no late deleterious effects on valve
function 5 to 10 years after surgery.3-5
We have proposed a classification of AVS surgery into 2
basic types: aortic valve reimplantation and remodeling of
the aortic root.6 In aortic valve reimplantation, the aortic
annulus, the aortic cusps, and a rim of the aortic sinuses
are placed inside a tubular Dacron graft and secured below
and above the aortic annulus, fixing the diameter and
shape of the aortic annulus and sinotubular junction. In
remodeling of the aortic root only, the aortic sinuses are
replaced with an appropriate Dacron graft to re-create the
normal scalloped shape of the aortic annulus, as originallyery c September 2014
Abbreviations and Acronyms
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David et al Acquired Cardiovascular Diseasedescribed by Sarsam and Yacoub.7 If the aortic annulus
were dilated, we combined AVS surgery with a reducing
annuloplasty by suturing a band of Dacron fabric on the
outside of the intervalvular fibrous body.8 Numerous
modifications to these 2 basic procedures have been
introduced.9-12
The present report describes the clinical and echocardio-
graphic outcomes of AVS operations at our institution
during the past 2 decades.A
C
DMETHODS
FromMay 1988 through December 2010, 371 consecutive patients with
an aortic root aneurysm or ascending aortic aneurysms and aneurysmal
aortic sinuses with or without aortic insufficiency (AI) underwent AVS
surgery. The clinical profile of all patients and the 2 main subgroups of
AVS operations are listed in Table 1. The pertinent operative data are listed
in Table 2. Reimplantation of the aortic valve was performed in 296
patients and remodeling of the aortic root in 75. During the first decade
of experience, no particular criteria were in use for choosing one or the
other type of AVS procedure. However, later in our experience, younger
patients with inherited aortic root aneurysm underwent the reimplantation
procedure exclusively, and older patients with ascending aortic aneurysm
and secondarily dilated aortic sinuses underwent the remodeling
procedure. We have described the technical aspects of our AVS operations
in recent studies.10,11
The patients were followed up prospectively with annual
echocardiographic studies during the first decade and every 2 to 3 years
thereafter if the aortic valve function had remained stable. Images of the
entire thoracic aorta were obtained every 5 years or more often if the patient
had had dissection or residual aneurysm at surgery. For the present report,
the follow-up period was closed December 31, 2013. The mean follow-up
duration was 8.9  5.2 years; 43 patients were followed up for>15 years
but only 11 for>20 years. The clinical follow-up data were complete, and
the echocardiographic studies were 98% complete during the most recent 3
years. The review ethic board of the University Health Network approved
the study.
Statistical Analysis
Data are presented as the mean  standard deviation or frequencies, as
appropriate. The variables and categories with low frequency are reported
as descriptive statistics but were collapsed (when possible) or excluded for
additional analyses. Basic comparisons between groups were performed
using Fisher’s exact test for all categorical variables and Student’s t test,
assuming an unequal variance between samples (Satterthwaite methods).
The freedom from time-dependent outcomes was modeled in a parametric
survival model (using maximum likelihood estimates to resolve risk) that
divides the risk over time in 3 distinct phases of risk (early, constant,
and late) using standard mathematical algorithms from the HAZARD pro-
cedure (available at: http://www.clevelandclinic.org/heartcenter/hazard).
All associations between the freedom from outcomes and the potential
predictors were first screened in univariable regression models. The
associations between patient and surgical characteristics and outcomesThe Journal of Thoracic and Cawere included in a bootstrap bagging algorithm (500 resamples). The
variables with high reliability (>50%; defined as the percentage of the
resample in which a given variable was selected) were then included in a
multivariable parametric survival regression model, with backward
selection of variables to obtain a final regression model. All risk factor
analyses were performed using a unified phase of risk, given the
limited number of events in some phases of risk. Life tables from the
Province of Ontario from 2000 to 2002 (available at: Statistics Canada,
www.statcan.gc.ca/pub/84-537-x/4064441-eng.htm) were used to estimate
the 20-year survival of the patient cohort according to the age and
gender distribution. Mean imputation was used to account for missing
variables. All statistical analyses were performed using SAS, version 9.3
(SAS Institute, Cary NC).
RESULTS
Perioperative Complications
Four patients died in hospital or within 30 days of
surgery. The cause of death was low cardiac output
syndrome in 1 patient, acute type B aortic dissection in 1,
Clostridium difficile colitis in 1, and perioperative
myocardial infarction in 1. Thirty-four patients (9.1%)
required reopening of the chest for bleeding and/or
pericardial tamponade. One patient required aortic root
replacement 2 days after surgery because of persistent AI.
One patient required re-exploration of the aortic root
because of acute thrombosis of both coronary artery orifices
with large white filamentous strands from a transient
undiagnosed hematologic disorder associated with
profound thrombocytopenia. One patient required
laparotomy to repair a liver rupture caused by cardiac
resuscitation. In addition, 4 patients experienced a
perioperative myocardial infarction, 2 developed renal
failure, 2 experienced a stroke, and 2 experienced a
transient ischemic attack. Seventy-six patients developed
new transient atrial fibrillation postoperatively. Four
patients (3 reimplantation and 1 remodeling) required
permanent transvenous pacemaker implantation because
of complete heart block in 2 patients and sick sinus
syndrome in 2. One patient developed sternal infection.
One half of all the patients required blood product
transfusion.
Late Mortality
A total of 39 late deaths occurred: 14 cardiovascular
related (1 stroke, 5 sudden death, 2 myocardial infarction,
and 6 related to complications of aortic dissection) and 25
non–cardiovascular-related deaths. Figure 1 shows the
patient survival compared with that of the general
population and matched for age and gender. The patients
who had undergone AVS surgery had lower survival rates
than the general population during the first 2 decades of
follow-up (P ¼ .001). The survival at various intervals is
listed in Table 3. The possible predictors of mortality on
univariable analysis are listed in Table 4. Multivariable
analysis disclosed that age by 5-year increment (hazard
ratio [HR], 1.41; 95% confidence interval [CI], 1.24-1.61;rdiovascular Surgery c Volume 148, Number 3 873
TABLE 1. Clinical characteristics of all patients and subgroups stratified by type of aortic valve sparing
Variable All patients Reimplantation Remodeling P value
Patients (n) 371 296 75 .000
Age (y) .008
Mean  SD 47.4  15.1 46.4  15.0 51.5  14.6
Range 11-79 11-79 21-77
Male gender 290 (78.1) 231 (78) 59 (78.6) 1.00
Clinical presentation
Chest pain 26 (7) 19 (6.4) 7 (9.3) .41
Heart failure 37 (10) 22 (7.4) 15 (20) .004
Shock 4 (1) 2 (0.6) 2 (2.7) .19
Syncope 8 (2.1) 7 (2.4) 1 (1.3) 1.00
Preoperative ECG findings
Sinus rhythm 353 (95.6) 286 (97.2) 67 (89.3) .04
Atrial fibrillation 14 (3.8) 7 (2.4) 7 (9.3) .01
Heart block or pacemaker 2 (0.5) 1 (0.3) 1 (1.3) .37
Urgent or emergency surgery 35 (9.4) 25 (8.4) 10 (13.3) .18
Previous cardiac surgery 19 (5.1) 14 (4.8) 5 (6.7) .56
NYHA functional class .28
I 212 (57.1) 175 (59.1) 37 (49.3)
II 96 (25.8) 76 (25.6) 20 (26.7)
III 27 (7.2) 19 (6.4) 8 (10.7)
IV 36 (9.7) 26 (8.7) 10 (13.3)
LVEF (%) .01
60 263 (71.2) 215 (72.8) 48 (64.8)
40-59 80 (21.6) 59 (20) 21 (28.3)
20-39 24 (6.5) 21 (7.1) 3 (4)
20 2 (0.5) 0 2 (2.7)
Associated disease
Marfan syndrome 131 (35.5) 108 (36.7) 23 (30.7) .35
Type A dissection .008
Acute 28 (7.2) 18 (6.1) 10 (13.3)
Chronic 17 (4.3) 10 (3.4) 7 (9.3)
Diabetes mellitus 11 (3.0) 9 (3.1) 2 (2.7) 1.00
Hypertension 145 (39.3) 115 (39.1) 30 (40) .90
Hyperlipidemia 75 (20.3) 62 (21.1) 13 (17.3) .52
Smoking 160 (43.8) 127 (43.6) 33 (44.6) .90
COPD (FEV1<1.0) 12 (3.3) 7 (2.4) 5 (6.7) .07
Stroke or TIA 10 (2.7) 7 (2.4) 3 (4.0) .43
PVD 5 (1.4) 5 (1.7) 0 .59
Renal failure (dialysis) 4 (1.1) 4 (1.4) 0 .59
Preoperative findings
Aortic root diameter (mm) 55  4 55  5 56  5 .81
Bicuspid aortic valve 34 (9.2) 32 (10.8) 2 (2.6) .03
Aortic regurgitation .35
None or trace 104 (30.9) 86 (32.3) 18 (25.7)
Mild 66 (19.6) 53 (19.9) 13 (18.5)
Moderate 89 (26.4) 64 (24) 25 (35.7)
Severe 77 (22.9) 63 (23.6) 14 (20)
Mitral regurgitation 31 (8.4) 25 (8.5) 6 (8) .96
Tricuspid regurgitation 1 1 0 1.00
PV dysfunction 2 2 0 1.00
Atrial septal defect 15 (4.0) 15 (5.1) 0 .05
Ventricular septal defect 3 3 0 1.00
Coronary artery disease 38 (10.2) 29 (9.8) 9 (12) .68
Data presented as mean standard deviation or n (%). ECG, Electrocardiographic; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; COPD, chronic
obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; PVD, peripheral vascular arterial disease; PV, pulmonary valve; SD, standard deviation; TIA, tran-
sient ischemic attack.
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Dacron graft diameter (mm) 31  4 28  4 <.001
Creation of neoaortic sinus 138 (46.6) 75 (100) <.001
Cusps shortened by plication (n) .02
1 55 (18.7) 21 (28)
2 41 (14) 2 (2.7)




1 62 (21.1) 16 (21.3)
2 7 (2.4) 3 (4)
3 2 (0.7) 0
Aortic arch replacement 39 (13.3) 21 (28) .004
Coronary artery bypass grafting 29 (9.8) 9 (12) .68
Patch angioplasty of left
main artery
5 (1.7) 0 .59
Mitral valve repair 25 (8.4) 6 (8) 1.00
Mitral valve replacement 1 (0.3) 0 1.00
Tricuspid valve repair 1 (0.3) 0 1.00
Pulmonary valve replacement 2 (0.7) 0 1.00
Repair of congenital heart defects 18 (6.1) 0 .03
Maze procedure 4 (1.4) 0 .59
Repair of abdominal aortic
aneurysm
1 (03) 0 1.00
Cardiopulmonary bypass
time (min)
141  32 126  32 .001
Aortic crossclamp time (min) 117  27 102  24 <.001
Circulatory arrest 45 (15.3) 21 (28) .02
Body surface area (m2) 2.04  0.26 2.05  0.27 .69
Body mass index (kg/m2) 26.5  4.9 27.1  5.0 .37
Data presented as mean  standard deviation or n (%).
FIGURE 1. Patient survival compared with the general population and
matched for age and gender.
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DP< .001), type A aortic dissection (HR, 2.18; 95% CI,
1.11-4.28; P ¼ .02), preoperative moderate or severe AI
(HR, 2.18; 95% CI, 1.07-4.47; P ¼ .03), and lower left
ventricular ejection fraction per grade (HR, 1.84; 95%
CI, 1.23-2.75; P ¼ .003) were independent predictors of
mortality.
Reoperations
Ten patients required reoperation on the aortic valve
(reimplantation in 5 and remodeling in 5). The indications
for repeat aortic valve surgery were AI in 8 patients
and infective endocarditis with aortic root abscess in 2
(1 reimplantation; 1 remodeling). The aortic valve was
repaired again in 1 patient and replaced in 9 patients (3
aortic valve replacement; 6 aortic root repeat replacement).
Of the 8 reoperations for AI, 7 were performed by us. The
mechanism of AI in 4 patients who underwent reimplanta-
tion of the aortic root was prolapse due to detachment of 1
cusp from its commissure (this valve was repaired again by
resuspension of the cusp with Gore-Tex suture), and cusp
prolapse with degenerative changes in the other 3. The
mechanism of AI in the 4 patients who had remodeling ofThe Journal of Thoracic and Cathe aortic root was cusp prolapse due to dilatation of the
aortic annulus (from 28  3 mm early postoperatively to
35  4 mm before reoperation). Remodeling of the aortic
root was marginally associated with a greater risk of
reoperation on univariable analysis (HR, 3.37; 95% CI,
0.88-12.82; P ¼ .07). Figure 2 shows the freedom from
reoperation on the aortic valve in all patients and in the 2
subgroups. The rates at various intervals are listed in
Table 3. In addition to aortic valve reoperations, 2 patients
required mitral valve repair, 1 patient, replacement of
the transverse arch using the elephant trunk technique,
and 1 patient, replacement of the entire thoracic and
abdominal aorta. No operative deaths occurred among the
patients who required reoperation, but 1 patient became
paraplegic.
Echocardiographic Studies
Eighteen patients developed moderate or severe AI
during the follow-up period (12 reimplantation; 6
remodeling). Although remodeling of the aortic root,
preoperative AI, bicuspid aortic valve, and preoperative
mitral regurgitation were associated with a greater risk of
AI on univariable analysis, no predictor of postoperative
AI was found on multivariable analysis. No patient had
more than mild AI on the echocardiogram taken before
discharge from the hospital, and this degree of early AI
was not a factor in the development of late AI on either
univariable or multivariable analysis. Similarly, the time
of the operation (early vs late experience) was not a factor
in the development of AI. Figure 3 shows the freedom
from moderate and severe AI in all patients and stratified
by reimplantation and remodeling. The rates at the various
intervals are listed in Table 3. In addition to AI, 24 patients
developed new moderate or severe mitral insufficiency. The
freedom from mitral insufficiency at various intervals is
also listed in Table 3.rdiovascular Surgery c Volume 148, Number 3 875
TABLE 3. Freedom from morbid events at various intervals
Freedom from
Follow-up point (y)
1 5 10 15 18
Mortality 97.3  0.8 94.6  1.2 89.0  2.0 79.7  3.4 76.8  4.3
Reoperation* 99.7  0.3 99.7  0.3 97.0  1.3 94.8  2.0 94.8  2.0
Aortic insufficiencyy 99.7  0.3 99.6  0.4 93.2  2.0 90.7  2.6 78.0  4.8
Mitral insufficiencyz 100 99.2  0.6 92.8  2.1 88.8  3.5 88.8  3.5
Thromboembolismx 99.5  0.4 96.6  1.0 94.1  1.5 92.2  2.4 90.1  3.2
Valve-related eventjj 98.1  0.6 95.5  1.1 91.2  2.4 85.5  3.8 79.4  4.6
Data presented as mean percentage standard deviation. *Reoperation on the aortic valve. yAortic insufficiency grade moderate or severe. zMitral insufficiency grade moderate
or severe. xTransient ischemic attack or stroke. jjValve-related death, reoperation, aortic insufficiency, thromboembolism, hemorrhage, and endocarditis.
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Four patients developed infective endocarditis (2 mitral,
treated with antibiotics alone; and 2 aortic, treated with
antibiotics and surgery). Six patients experienced a stroke
and 19 transient ischemic attacks. The freedom from
thromboembolic events at various intervals is listed in
Table 3. At the latest follow-up point, 39 patients were
taking an oral anticoagulant because of atrial fibrillation,
pacemaker implantation, or a previous thromboembolic
event, and 8 had experienced anticoagulation-related
hemorrhage. The freedom from any valve-related adverse
event is listed in Table 3. Two patients experienced a
myocardial infarction. Ten patients required permanent
transvenous pacemaker implantation because of heart block
or sick sinus syndrome (7 reimplantation; 3 remodeling).
Functional Class
At the most recent follow-up visit, 319 patients were
alive and had their native aortic valve. Of these patients,TABLE 4. Factors associated with increased hazard of mortality on
univariable analysis (P<.05)
Potential predictor HR 95% CI P value
Older age at surgery (per yr) 1.074 1.049-1.100 <.001
Higher NYHA functional class (per level) 1.650 1.292-2.108 <.001
Lower LVEF (per level) 2.336 1.659-3.289 <.001
Preoperative hypertension 3.693 1.960-6.958 <.001
Symptoms of heart failure 4.663 2.501-8.695 <.001
Serum creatinine>50 mmol/L 1.172 1.087-1.263 <.001
Coronary artery disease (per vessel) 1.762 1.304-2.383 <.001
Longer CPB time (per 30 min) 1.628 1.316-2.014 <.001
Longer aortic crossclamp time
(per 30 min)
1.732 1.300-2.308 <.001
Circulatory arrest 3.385 1.850-6.192 <.001
Aortic arch replacement 3.071 1.668-5.654 <.001
Type A aortic dissection 2.066 1.379-3.093 <.001
Preoperative moderate or severe AI 3.070 1.492-6.317 .002
Hyperlipidemia 2.564 1.313-5.009 .006
Marfan syndrome 0.360 0.171-0.755 .007
Any previous cardiac surgery 3.612 1.262-10.33 .02
HR, Hazard ratio; CI, confidence interval; NYHA, New York Heart Association;
LVEF, left ventricular ejection fraction; CPB, cardiopulmonary bypass; AI, aortic
insufficiency.
876 The Journal of Thoracic and Cardiovascular Surg80% were in New York Heart Association class I, 15% in
class II, and 5% in class III.
DISCUSSION
The results of the present study have provided additional
information on the clinical and echocardiographic
outcomes after AVS operations to treat patients with aortic
root aneurysms or ascending aortic aneurysms and dilatedFIGURE 2. Freedom from reoperation on the aortic valve, upper, for all
patients and, lower, after reimplantation and remodeling procedures.
ery c September 2014
FIGURE 3. Freedom from moderate or severe aortic insufficiency, upper,
in all patients and, lower, after reimplantation and remodeling procedures.
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Daortic sinuses with or without AI. When these operations
were first developed, we did not distinguish the aortic
root aneurysms, such as those in patients with Marfan
syndrome, from the aortic sinus dilatation associated with
ascending aortic aneurysms.2,6 Patients with aortic root
aneurysm will usually be in their second, third, or fourth
decade of life, and the aneurysms will frequently be
associated with an inherited disorder such as Marfan
syndrome, Loyes-Dietz syndrome, familial aneurysms, or
osteoarthritis aneurysm syndrome when they come to
surgical attention. The aneurysm will almost always have
begun in the aortic sinuses and expanded proximally and
distally into the aortic annulus and sinotubular junction.
Patients with an ascending aortic aneurysm and dilated
aortic sinuses will usually be in their fifth, sixth, and seventh
decades of life, and the aneurysm will have begun in
the ascending aorta and expanded proximally into the
sinotubular junction and aortic sinuses (but seldom into
the aortic annulus) and distally into the aortic arch. The
dilatation of the aortic sinuses will often be asymmetric,
and the noncoronary aortic sinus will be the first to dilate,The Journal of Thoracic and Cafollowed by the right and left. Bicuspid aortic valve disease
is a different entity. When the valve becomes incompetent,
it will frequently be associated with dilatation of the aortic
annulus. Patients with inherited aortic root aneurysm
could also have a bicuspid aortic valve. We believe this
heterogeneity of pathologic entities must be accounted for
when selecting the type of AVS to treat the aortic sinus
aneurysm.
AVS operations were developed to restore the anatomy
and function of the aortic root. Given the anatomy of the
aortic annulus and aortic cusps, the areas of the aortic cusps
must be much larger than the area of the aortic annulus.
Thus, as long as no mismatch is present between the size
of the aortic cusps and the size of the aortic annulus,
replacement of the aneurysmal aortic sinuses with
adjustment of the diameter of the sinotubular junction and
correction of any cusp prolapse will re-establish the
normal aortic valve function in patients with ascending
aortic aneurysms and dilated aortic sinuses. Therefore,
remodeling of the aortic root is ideally suited for these
patients, and evidence has shown that this procedure will
be very durable in such circumstances.11,15 No patient in
our series who had undergone remodeling of the aortic
root required reoperation or developed recurrent AI, if the
patients with Marfan syndrome were excluded. However,
patients with genetic aortic root aneurysms and patients
with incompetent bicuspid aortic valves will often have a
dilated aortic annulus, and remodeling of the aortic root
in this subset has resulted in suboptimal long-term
results.16-18 Reimplantation of the aortic valve is ideally
suited for patients with a dilated aortic annulus. This
procedure reduces the diameter and reshapes the aortic
annulus by fixing it into the cylindrical Dacron graft but
places the aortic cusps into a noncompliant structure. The
selection of the graft size for the reimplantation procedure
is crucial and difficult. Although the height of the aortic
cusps, length of their free margins, height of the
commissures, and diameter of the aortic annulus and/or
sinotubular junction have been used to estimate the
diameter of the graft, no single measurement will give the
correct diameter, because the components of the aortic
root will often be abnormal in patients with aortic root
aneurysm.2,13,14,19,20 We believe that the height of the
cusp is the single most important parameter for estimating
the graft diameter. The radius of the aortic annulus at the
level of the nadir of the cusps should be approximately
two thirds of the height of cusps. Because the graft lies on
the outside of the aortic annulus, 3 to 4 mm should be
added to the estimated internal diameter to compensate
for the thickness of the aortic annulus.2
Another controversial issue with AVS operations is
whether the creation of neoaortic sinuses is important for
valve function. Undoubtedly, placing the cusps inside a
rigid, noncompliant structure such as a cylindrical Dacronrdiovascular Surgery c Volume 148, Number 3 877
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the cusps, alter the bending characteristics of the cusps
during the cardiac cycle, and probably increase the
mechanical stress on the cusps.21-23 We have never used
the Valsalva graft,23 because the aortic annulus will be
placed inside a spherical structure instead of a cylindrical
structure, such as nature created the semilunar valves. We
have created neoaortic sinuses by placing darts in a tubular
Dacron graft in the spaces between the commissures,13,14
but we have been unable to show that artificially created
sinuses improve the durability of the AVS procedure.
Thus, we have only plicated the spaces in between
commissures if, after implanting the aortic valve into a
tubular Dacron graft, we have found that the
intercommissural distance of a given cusp prevents the
cusp from coapting with others. Thus, plication of 1
intercommissural spaces will be used to optimize cusp
coaptation rather than to create a neoaortic sinus.
Survival after the AVS procedure in our series was less
than that of the general population matched for age and
gender. This was not surprising, given the extensiveness
of the associated disorders that many of our patients had.
Only 8 patients have required reoperation for AI.
Statistical modeling is difficult with such a small number
of adverse events to determine the causes of failure. The
same can be said about the type of AVS. Experience from
multiple centers has shown that certain technical aspects
of the AVS procedure play an important role in postopera-
tive aortic valve function. With both techniques of AVS,
uncorrected cusp prolapse has probably been the most
common cause of early valve failure.3,24,25 In addition,
the level of coaptation of the aortic cusps in relation to
the aortic annulus appears to be very important, in
particular, after the reimplantation procedure.25,26 Just as
in the normal aortic root, the cusps should coapt within
the aortic root, with several millimeters above the nadir of
the aortic annulus, regardless of the type of AVS
procedure performed. The coaptation length and
coaptation height are determined by a complex
relationship among the diameter of the graft used, length
of the free margin of the cusp, height of the cusp, height
of the commissures, and intercommissural distances. We
believe that the diameter of the graft used for
reconstruction of the aortic root is crucial with both
techniques. Once the aortic annulus and sinotubular
junction have been stabilized with a Dacron graft, careful
assessment of the cusps and the level at which they coapt
in relation to the aortic annulus should be performed and
corrected if needed. The coaptation level can be raised by
shortening the free margin of the cusp, either by plication
along the nodule of Arantius or with a double-layer of a
fine Gore-Tex suture along the free margin from commis-
sure to commissure.4,5 If a cusp lies too high and barely
touches the other 2, a reduction of the intercommissural878 The Journal of Thoracic and Cardiovascular Surgdistance will lower the level of the free margin. Thus, just
as with any valve reconstructive procedure, a sound
knowledge of the functional anatomy and how the various
components interplay is indispensable for a good
functional result. We only began to collect information
regarding the cusps’ coaptation height and coaptation
length after the findings reported by Kunihara and
colleagues.25 Because our data set did not contain this
variable, it is possible that an inadequate repair could
have contributed to the development of late AI. Finally,
we found an unexpectedly high proportion of new moderate
or severe mitral insufficiency in our patients during
follow-up, regardless of the type of AVS surgery used.
This finding underscores the importance of continued
echocardiographic surveillance in these patients.
Study Limitations
Although our experience with AVS operations spanned
more than one quarter of century, we had only 43 patients
at risk after 15 years and 11 after 20 years. Thus, the
outcomes after 15 years might not be statistically valid,
despite the type of analysis used. Because a large number
of late echocardiographic studies were performed and
interpreted outside of our hospital, one could question the
validity of the results. Also, we might have underestimated
the severity of the aortic valve dysfunction. Finally, because
we did not have echocardiographic data such as the cusp
coaptation height and coaptation length, we could have
missed factors predictive of recurrent AI.
CONCLUSIONS
AVS operations have become a part of the surgical
armamentarium for treating patients with aortic root
aneurysms and ascending aorta aneurysms with dilated
aortic sinuses. We believe that reimplantation of the aortic
valve is ideal for younger patients with inherited aortic
root aneurysms and that remodeling of the aortic root is
ideal for older patients with ascending aortic aneurysms,
dilated aortic sinuses, and a normal aortic annulus. The
long-term results have continued to be excellent; however,
valve function appeared to deteriorate slowly during the
second decade of follow-up. AVS operations will be
feasible for most, if not all, patients with normal or mildly
stretched aortic cusps. Recent knowledge of the importance
of cusp configuration after reconstruction of the aortic root
should enhance the durability of AVS operations.25
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Dr Hans-Joachim Sch€afers (Homburg/Saar, Germany). It is
a privilege for me to discuss this important contribution from
Dr David and his coworkers, Dr David being a true pioneer inThe Journal of Thoracic and Cavalve-preserving aortic replacement. You have demonstrated the
durability of preservation of the aortic valve reaching 25 years,
although only 43 patients were beyond 15 years at this point.
Nevertheless, excellent results.
An interesting finding in your present review was that in
patients withoutMarfan syndrome, remodeling and reimplantation
actually achieved similar results. Interesting, of course, and we
always have to learn from our failures, is the question, what
happened to the aortic valve in the 8 patients in whom you
reoperated electively for aortic regurgitation? In this context, if
we have learned something, and I have also learned from you, it
is important to achieve a normal aortic valve configuration at the
end of the operation, with cusp plication or correction of cusp
prolapse an integral part of the procedure.
My question to you is, has there been a learning curve for you?
In other words, have you increased the percentage of cusp
manipulations over time?
Finally, in terms of selecting valve preservation, have there been
morphologic findings at the operation that would now prompt
you to abort the repair and perform replacement (ie, extensive
fenestrations, cusp retractions, or calcification)?
Again, my congratulations for this important pioneering work
and an excellent presentation.
Dr David (Toronto, Ontario, Canada). Thank you, Dr Sch€afers.
Your contributions to this area are also commendable. To be quite
honest, we learned from you the importance of the coaptation
height and coaptation area. However, before that, we did not enter
these variables into our database; thus, we could not determine
whether these patients had had an inadequate repair. To study
echocardiograms from 20 years ago would be almost impossible,
because in those days, they were only on video, and most were
destroyed. So, I do not know the answer for that.
Reviewing the operative reports of those patients in whom the
aortic valve reoperation was done for AI, all the patients had
cusp prolapse, except for 1, in whom the cusps were calcified
and had developed a mixed lesion. I do believe that by giving
more attention to the technical aspects that you emphasized on
the proper coaptation and leaflet geometry at the end of the
operation, we might improve on these results.
Before I embarked on this type of operation, I had quite
extensive experience with stentless valves. Thus, unlike most
surgeons, I did not experience a learning curve. From the
beginning, we knew what was required to make a stentless valve
competent, and we might have abolished the learning curve with
aortic valve sparing. What we did not know, however, was the
pathologic features of the aortic annulus. I had no idea 25 years
ago that a larger aortic annulus was a sign of a more extensive
connective tissue disorder.
The selection of patients is crucial, of course. More than one
half of our patients had either leaflet fenestration or leaflet
prolapse. Repairing them did not cause recurrent AI. Thus, the
outcomes 15 and 20 years later appeared to be unaffected by
leaflet repair at surgery. I believe those patients should be included
as candidates for aortic valve repair.
Calcification or even sclerosis is different. I should add an
observation made in my operative notes. I described whether the
cusps were elastic or sclerotic. Elastic cusps provided the best
long-term outcomes. I think they are adaptable to a rigid structure,rdiovascular Surgery c Volume 148, Number 3 879
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Dparticularly in the reimplantation technique. That is why younger
patients will do better than older ones with reimplantation.
These 2 operations are not competitive; each one has a place,
and, in my opinion, older patients, older than 40 or 50 years, should
undergo remodeling if the annulus is normal, with reimplantation
reserved for genetic aneurysms.
Dr Lars G. Svensson (Cleveland, Ohio). Tirone, once again, a
great presentation, and as I have said before to you, thank you for
teaching me this wonderful operation.
We have done some 440 David reimplantations now, and I agree
with you entirely that the long-term results have been excellent.
We hope to live up to your standards, but valve failure is not an
issue. We have had a couple of patients with endocarditis, so
that certainly can happen. In your series, just as we have seen
also, the risk of dissection is still prevalent in these patients,
even if the distal aorta is of normal size. Nearly one half of your
14 cardiovascular deaths were related to dissection. Thus, one of
my questions is, what are you doing about monitoring those
patients? We have seen patients with a normal descending aorta880 The Journal of Thoracic and Cardiovascular Surghave a successful David procedure and then come back 1 year later
with dissection.
Also, perhaps you could comment on the controversy—
obviously all of us use b-blockers in high-risk patients—–regarding
the use of losartan after surgery and whether you think that makes
any difference.
Dr David. That is a very good point, because the operation does
not seem to abolish the risk of dissection beyond the area that has
been replaced. I did not give the incidence of dissection, but it
remains a problem in patients with genetic aneurysms. Many
patients such as yours will have had a successful operation and
2, 3, 5 years later will have developed a type B dissection,
particularly the subgroup with Marfan syndrome.
We encourage every young patient to take b-blockers
permanently. Whether they will or not is a different story. However,
I do not know of anything we can do to abolish the risk of dissection
in patients with connective tissue disorder other than giving
losartan or b-blockers. It would be interesting to know what can be
done to prevent this dreadful complication of aortic root aneurysms.ery c September 2014
